KHB

同壁财经 · May 20 at 01:36 AM

KHB (002022): Won the procurement project of Tangshan Central Blood Station, with a bid amount of 1.1827 million yuan

36Kr · Jan 28 at 02:00 AM

KHB: The holding subsidiary Tianlong Company has a comprehensive solution for Nipah virus testing

Wallstreetcn · Jan 25 at 11:15 PM

The A-share biopharmaceutical sector continues to strengthen, with Maccura, Hybribio Biotech, and KHB hitting the daily limit up in the afternoon. LIFERIVER and DAJY had previously reached their limit up, while WONDFO BIOTECH, ACROBIOSYSTEMS, Orient Biotech, and SSSW rose over 10%

Zhitong · Oct 29, 2025 at 06:43 AM

KHB: Net profit loss of 99.0801 million yuan in the third quarter, a decrease of 42.20%

Zhitong · Sep 18, 2025 at 02:56 AM

KHB's product has obtained a medical device registration certificate

Zhitong · Sep 17, 2025 at 03:40 AM

KHB convertible bond repurchase results announced, 70 bonds repurchased for a total amount of 7,016.87 yuan